443 related articles for article (PubMed ID: 25514746)
1. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
2. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
[TBL] [Abstract][Full Text] [Related]
3. Biological impact of advanced glycation endproducts on estrogen receptor-positive MCF-7 breast cancer cells.
Matou-Nasri S; Sharaf H; Wang Q; Almobadel N; Rabhan Z; Al-Eidi H; Yahya WB; Trivilegio T; Ali R; Al-Shanti N; Ahmed N
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2808-2820. PubMed ID: 28712835
[TBL] [Abstract][Full Text] [Related]
4. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.
Pan B; Ren H; Ma Y; Liu D; Yu B; Ji L; Pan L; Li J; Yang L; Lv X; Shen X; Chen B; Zhang Y; Willard B; He Y; Zheng L
Int J Cancer; 2012 Jul; 131(1):70-82. PubMed ID: 21805479
[TBL] [Abstract][Full Text] [Related]
7. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
8. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
[TBL] [Abstract][Full Text] [Related]
9. Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway.
Meng HZ; Zhang WL; Liu F; Yang MW
J Biol Chem; 2015 Nov; 290(47):28189-28199. PubMed ID: 26472922
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
Tafani M; Schito L; Pellegrini L; Villanova L; Marfe G; Anwar T; Rosa R; Indelicato M; Fini M; Pucci B; Russo MA
Carcinogenesis; 2011 Aug; 32(8):1167-75. PubMed ID: 21642357
[TBL] [Abstract][Full Text] [Related]
11. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells.
Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR
Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.
Chuang PY; Yu Q; Fang W; Uribarri J; He JC
Kidney Int; 2007 Oct; 72(8):965-76. PubMed ID: 17667983
[TBL] [Abstract][Full Text] [Related]
15. Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro.
Aljohi A; Matou-Nasri S; Liu D; Al-Khafaji N; Slevin M; Ahmed N
Food Funct; 2018 Nov; 9(11):5728-5739. PubMed ID: 30318521
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2013 May; 45(5):387-90. PubMed ID: 23225247
[TBL] [Abstract][Full Text] [Related]
18. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
20. Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo.
Kim YS; Kim J; Kim KM; Jung DH; Choi S; Kim CS; Kim JS
Biochem Pharmacol; 2015 Feb; 93(4):496-505. PubMed ID: 25450667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
